HIC1 and acute myeloid leukemia: They analyzed the methylation of CDKN2B, E-cadherin (CDH) and hypermethylated in cancer 1 (HIC1) promoters, and global DNA methylation in 107 AML patients by the luminometric methylation assay (LUMA).